Bio Techne Correlations

TECH Stock  USD 59.65  0.84  1.43%   
The current 90-days correlation between Bio Techne Corp and Moderna is 0.24 (i.e., Modest diversification). The correlation of Bio Techne is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Bio Techne Correlation With Market

Very weak diversification

The correlation between Bio Techne Corp and DJI is 0.42 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bio Techne Corp and DJI in the same portfolio, assuming nothing else is changed.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Bio Techne Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Moving together with Bio Stock

  0.67A Agilent TechnologiesPairCorr
  0.77QGEN Qiagen NVPairCorr

Moving against Bio Stock

  0.49DB Deutsche Bank AGPairCorr
  0.32MZHOF Mizuho Financial Normal TradingPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

RVMDMDGL
JAZZMDGL
MDGLEXEL
RVMDJAZZ
RVMDRNA
RVMDEXEL
  

High negative correlations

CAIMDGL
CAIRNA
RVMDCAI
JAZZCAI
CAIEXEL
QGENRNA

Risk-Adjusted Indicators

There is a big difference between Bio Stock performing well and Bio Techne Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bio Techne's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MRNA  3.06  0.21  0.07  0.14  3.72 
 6.85 
 22.21 
EXEL  1.71  0.06  0.02  0.12  2.52 
 4.27 
 14.78 
BMRN  1.50  0.11  0.07  0.17  1.43 
 3.20 
 20.77 
MDGL  2.01  0.37  0.22  0.47  1.33 
 7.29 
 12.14 
RNA  1.96  0.80  0.59  0.69  0.23 
 4.86 
 42.94 
CAI  2.36 (0.14) 0.00 (0.20) 0.00 
 4.40 
 22.72 
JAZZ  1.55  0.48  0.25 (0.77) 1.17 
 3.66 
 24.53 
RVMD  1.62  0.76  0.60  0.94  0.61 
 4.34 
 11.71 
QGEN  0.98 (0.01)(0.03) 0.03  1.19 
 2.56 
 7.00 
CORT  3.37 (1.02) 0.00 (0.23) 0.00 
 4.66 
 58.23 

Bio Techne Corporate Management

Lynne HohlfeldSenior DivisionProfile
Steven CrouseSenior DivisionProfile
Gerry AndrosVice MarketingProfile
Bernie AndrussSenior DivisionProfile
Kim KeldermanPres GenomicsProfile
Dylan MalayterSenior DivisionProfile